Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Zeitschrift Fur Gastroenterologie
|
January 7, 2012
[Epidemiology and clinical characteristics of patients with chronic hepatitis B (CHB) in Germany - results of a nationwide cross-sectional study]
C Fischer, S Mauss, E Zehnter, et al.
Zeitschrift Fur Gastroenterologie
|
March 20, 2002
Non-invasive evaluation of activity in inflammatory bowel disease by power Doppler sonography
R Heyne, S Rickes, P Bock, et al.
Physical Review Letters
|
March 5, 2009
High-resolution laser spectroscopy on the negative osmium ion
U Warring, M Amoretti, C Canali, et al.
Journal of Viral Hepatitis
|
July 6, 2012
High-dose silibinin rescue treatment for HCV-infected patients showing suboptimal virologic response to standard combination therapy
M Biermer, B Schlosser, B Fülöp, et al.
Journal of Viral Hepatitis
|
March 16, 2013
Screening for autoantibodies in chronic hepatitis C patients has no effect on treatment initiation or outcome
S Mauss, F Berger, A Schober, et al.
European Journal of Biochemistry
|
July 24, 2002
S-decyl-glutathione nonspecifically stimulates the ATPase activity of the nucleotide-binding domains of the human multidrug resistance-associated protein, MRP1 (ABCC1)
Robbert H Cool, Marloes K Veenstra, Wim van Klompenburg, et al.
Journal of Viral Hepatitis
|
February 18, 2010
Efficacy and tolerability of peginterferon alfa-2a or alfa-2b plus ribavirin in the daily routine treatment of patients with chronic hepatitis C in Germany: the PRACTICE study
T Witthoeft, D Hueppe, C John, et al.
Journal of Viral Hepatitis
|
September 21, 2010
Estimating the likelihood of sustained virological response in chronic hepatitis C therapy
S Mauss, D Hueppe, C John, et al.
Zeitschrift Fur Gastroenterologie
|
January 12, 2008
[Epidemiology of chronic hepatitis C in Germany--an analysis of 10,326 patients in hepatitis centres and outpatient units]
D Hüppe, E Zehnter, S Mauss, et al.
Journal of Viral Hepatitis
|
March 26, 2017
Real-world experience with the all-oral, interferon-free regimen of ombitasvir/paritaprevir/ritonavir and dasabuvir for the treatment of chronic hepatitis C virus infection in the German Hepatitis C Registry
T M Welzel, H Hinrichsen, C Sarrazin, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Zeitschrift Fur Gastroenterologie
|
January 7, 2012
[Epidemiology and clinical characteristics of patients with chronic hepatitis B (CHB) in Germany - results of a nationwide cross-sectional study]
C Fischer, S Mauss, E Zehnter, et al.
Zeitschrift Fur Gastroenterologie
|
March 20, 2002
Non-invasive evaluation of activity in inflammatory bowel disease by power Doppler sonography
R Heyne, S Rickes, P Bock, et al.
Physical Review Letters
|
March 5, 2009
High-resolution laser spectroscopy on the negative osmium ion
U Warring, M Amoretti, C Canali, et al.
Journal of Viral Hepatitis
|
July 6, 2012
High-dose silibinin rescue treatment for HCV-infected patients showing suboptimal virologic response to standard combination therapy
M Biermer, B Schlosser, B Fülöp, et al.
Journal of Viral Hepatitis
|
March 16, 2013
Screening for autoantibodies in chronic hepatitis C patients has no effect on treatment initiation or outcome
S Mauss, F Berger, A Schober, et al.
European Journal of Biochemistry
|
July 24, 2002
S-decyl-glutathione nonspecifically stimulates the ATPase activity of the nucleotide-binding domains of the human multidrug resistance-associated protein, MRP1 (ABCC1)
Robbert H Cool, Marloes K Veenstra, Wim van Klompenburg, et al.
Journal of Viral Hepatitis
|
February 18, 2010
Efficacy and tolerability of peginterferon alfa-2a or alfa-2b plus ribavirin in the daily routine treatment of patients with chronic hepatitis C in Germany: the PRACTICE study
T Witthoeft, D Hueppe, C John, et al.
Journal of Viral Hepatitis
|
September 21, 2010
Estimating the likelihood of sustained virological response in chronic hepatitis C therapy
S Mauss, D Hueppe, C John, et al.
Zeitschrift Fur Gastroenterologie
|
January 12, 2008
[Epidemiology of chronic hepatitis C in Germany--an analysis of 10,326 patients in hepatitis centres and outpatient units]
D Hüppe, E Zehnter, S Mauss, et al.
Journal of Viral Hepatitis
|
March 26, 2017
Real-world experience with the all-oral, interferon-free regimen of ombitasvir/paritaprevir/ritonavir and dasabuvir for the treatment of chronic hepatitis C virus infection in the German Hepatitis C Registry
T M Welzel, H Hinrichsen, C Sarrazin, et al.
Page
of 1